These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 5279031)
21. [Cardiac complications observed during treatment with rubidomycin]. Macrez C; Marneffe-Lebrequier H; Ripault J; Clauvel JP; Jacquillat C; Weil M Pathol Biol; 1967 Oct; 15(19):949-53. PubMed ID: 4869773 [No Abstract] [Full Text] [Related]
22. [Rubidomycin in cases of promyelocytic acute leukemia in children]. Wyszkowski J; Armata J; Garwicz S; Halikowski B Pol Tyg Lek; 1969 Oct; 24(45):1738-9. PubMed ID: 4903532 [No Abstract] [Full Text] [Related]
23. [The chemotherapy of acute promyelocytic leukemia with a new antileukemic agent "neocarzinostatin" (author's transl)]. Nagao T; Kamimura O; Fuchimoto T; Chen H; Toki H Rinsho Ketsueki; 1974 Sep; 15(9):1021-7. PubMed ID: 4530880 [No Abstract] [Full Text] [Related]
24. [Rubidomycin in acute leukemia]. Böttiger LE Lakartidningen; 1971 Jun; 68(26):2984-6. PubMed ID: 5284170 [No Abstract] [Full Text] [Related]
25. [High frequency and quality of remissions in acute lymphoblastic leukemia in children induced by the association of delta-1-cortisone, leurocristine and rubidomycin importance of rooms free of pathogenic germs]. Mathe G; Hayat M; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR; Jasmin C Arch Fr Pediatr; 1968 Feb; 25(2):181-7. PubMed ID: 5245333 [No Abstract] [Full Text] [Related]
26. Rubidomycin in acute leukaemia in adults. Malpas JS; Scott RB Br Med J; 1968 Jul; 3(5612):227-9. PubMed ID: 5243015 [TBL] [Abstract][Full Text] [Related]
27. [Attempts at treatment of acute leukemia with L-asparaginase]. Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225 [No Abstract] [Full Text] [Related]
28. Androgen therapy during myeloblastic leukemia remission induced by two drug combinations. Pavlovsky S; Scaglione C; Eppinger-Helft M; Muriel FS; Macchi A; Garay G; Cavagnaro F; Birman V; Dupont J; Suarez A; Dragosky MO; Barros CA Medicina (B Aires); 1981; 41(1):11-8. PubMed ID: 7022104 [No Abstract] [Full Text] [Related]
29. [Treatment of acute nonlymphocytic leukemia in children]. Tawa A; Kawa K; Ikeda T; Okuni H; Okubo Y; Masaoka T; Nishida M; Nishikawa A; Yoshioka K; Yoshioka A; Miyake M; Konishi S; Fujinani A; Tsujino G Rinsho Ketsueki; 1982 Apr; 23(4):476-83. PubMed ID: 6957629 [No Abstract] [Full Text] [Related]
30. Induction of remission in myeloblastic and monoblastic leukaemia in adults with rubidomycin. Toghill PJ; Ryrie DR; Tanna MK; Tattersall RB Acta Haematol; 1971; 46(2):65-73. PubMed ID: 5001572 [No Abstract] [Full Text] [Related]
31. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia. Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970 [TBL] [Abstract][Full Text] [Related]
32. Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome. Callera F; Lopes CO; Rosa ES; Mulin CC Leuk Res; 2008 Oct; 32(10):1633-4. PubMed ID: 18405970 [No Abstract] [Full Text] [Related]
33. Multidrug resistance: clinical relevance in acute leukemia. List AF Oncology (Williston Park); 1993 Oct; 7(10):23-8, 32; discussion 32, 35-8. PubMed ID: 7902728 [TBL] [Abstract][Full Text] [Related]
34. [Effect of rubomycin C on hemopoietic cells in vitro in various forms of acute leukemia]. Gerasimova NA; Dul'tsina SM Probl Gematol Pereliv Krovi; 1970 Oct; 15(10):26-31. PubMed ID: 5285584 [No Abstract] [Full Text] [Related]
35. [Abolition of delayed hypersensitivity reactions and the severity of aplasias induced by rubidomycin]. Kourilsky FM; Dupuy JM; Fradelizi D; Jacquillat C; Bernard J Pathol Biol; 1967 Oct; 15(19):959. PubMed ID: 4869775 [No Abstract] [Full Text] [Related]
36. [Treatment of acute leukemias]. Gross R; Gerecke D Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072 [TBL] [Abstract][Full Text] [Related]
37. [Possibly cardiotoxic action of miconazol injection fluid]. Huijgens PC; Boeijinga JK; van der Meer J Ned Tijdschr Geneeskd; 1975 Oct; 119(40):1549-51. PubMed ID: 52126 [No Abstract] [Full Text] [Related]
38. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia]. Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266 [No Abstract] [Full Text] [Related]
39. [Treatment of acute myeloblastic leukemia by rubidomycin. Statistics on 35 cases]. Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B Lille Med; 1969 Mar; 14(3):257-63. PubMed ID: 5261958 [No Abstract] [Full Text] [Related]
40. [Treatment of acute myeloblastic leukemia by the combination of daunorubicin (or rubidazone) and cytosine arabinoside (apropos of 76 cases)]. Bauters F; Jouet JP; Huart JJ; Jude B; Toussaint B; Goudemand M Lille Med; 1980 Dec; 25(10):559-68. PubMed ID: 6936592 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]